AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 113 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,434,000 | +170.6% | 150,662 | +134.3% | 0.01% | +133.3% |
| Q3 2015 | $530,000 | +829.8% | 64,314 | +1736.0% | 0.00% | – |
| Q2 2015 | $57,000 | -94.4% | 3,503 | -81.4% | 0.00% | -100.0% |
| Q4 2014 | $1,020,000 | +21.7% | 18,880 | -23.0% | 0.01% | +25.0% |
| Q3 2014 | $838,000 | – | 24,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|